Tecomet completes acquisition of Symmetry Medical's OEM Solutions business

Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's (NYSE: SMA) OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents.

The Symmetry Medical OEM Solutions business is a leading supplier of contract manufacturing and product solutions for the surgical instrument, orthopedic implant, and sterilization case and tray markets. The strategic capabilities of the OEM Solutions business provide a complementary fit with the existing Tecomet business.

Bill Dow, Chief Executive Officer of Tecomet, said, "With this acquisition, Tecomet adds to an already wide array of services and creates a footprint that would take decades to build organically. We will continue to be dedicated to providing our customers the best service at the highest level of quality at competitive prices."

Rob Rutledge, Principal of Genstar Capital, added, "This is a great opportunity to have a transforming impact on the orthopedic contract manufacturing industry. Original Equipment Manufacturers are moving more of their manufacturing out to contract manufacturers that can handle the volume and provide the systems support. This merger provides a contract manufacturing platform paramount to anything else in the orthopedic industry."

UBS Investment Bank acted as exclusive financial advisor and Weil, Gotshal & Manges LLP acted as legal advisor to Tecomet in connection with the transaction.

Source:

Tecomet Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
UPM Biomedicals launches FibGel™ the world's first injectable nanocellulose hydrogel for medical devices